Back

Liver native T1 mapping for predicting cardiovascular outcomes across stages of heart failure

1 September 2025 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Cardiac magnetic resonance and multiorgan biomarkers in cardiopulmonary and metabolic disease T1 and T2 Mapping ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Ayako Tezuka

Tokyo Medical University Hospital, Tokyo (Japan)

5 More presentations in this session

Presentation thumbnail
Exercise right ventricular global longitudinal strain as a marker for exercise tolerance in patients with chronic thromboembolic pulmonary disease
Doctor M. Imabayashi (Fukuoka, JP)
Abstract Slides Video
Presentation thumbnail
Left heart involvement in pulmonary hypertension translates to gradual left atrial functional impairment
Doctor B. Schmermund (Bad Nauheim, DE)
Abstract Slides Video
Presentation thumbnail
Prognostic value of pulmonary circulation parameters in patients with idiopathic recent-onset dilated cardiomyopathy
Doctor L. Opatril (Brno, CZ)
Abstract Slides Video
Presentation thumbnail
Association of non-invasive blood markers of liver fibrosis and growth differentiation factor with indices of cardiac function in diabetic patients: a CMR based study
Professor G. Georgiopoulos (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Renal T1 times reference values to improve risk stratification in patients with concomitant cardiac and renal disease: A 1.5 T CMR study
Doctor L. Lunzer (Vienna, AT)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac magnetic resonance and multiorgan biomarkers in cardiopulmonary and metabolic disease

The Event

Event poster

ESC Congress 2025

1 September 2025 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Advanced risk stratification in non-ischemic cardiomyopathy: the prognostic role of cardiac magnetic resonance
thumbnail
Congress Presentation
Prognostic value of liver fibrotic markers in patients with heart failure
thumbnail
Congress Presentation
Novel LiverRisk score is associated with adverse outcome in heart failure: insights from the BIOSTAT-CHF study

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources